Last updated: November 24, 2023
Sponsor: University of Leicester
Overall Status: Active - Recruiting
Phase
N/A
Condition
Birth Defects
Holoprosencephaly
Treatment
cardiovascular magnetic resonance
Clinical Study ID
NCT05221853
0768
270285
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients aged ≥ 18 years
- Referred for routine CMR imaging
- Willing and able to give informed consent
- Willing and able to comply with the requirements of the study
- Able to understand written English
Exclusion
Exclusion Criteria:
- Severe claustrophobia
- Absolute contraindications to CMR (those with CMR conditional or safe devices will beeligible for inclusion)
- Unable to provide informed consent
- Participants unable to understand written English
Study Design
Total Participants: 570
Treatment Group(s): 1
Primary Treatment: cardiovascular magnetic resonance
Phase:
Study Start date:
February 23, 2021
Estimated Completion Date:
February 01, 2025
Study Description
Connect with a study center
Glenfield Hospital
Leicester, Leics LE3 9QP
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.